Bridgeway Capital Management, LLC Decibel Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.08 - $4.79 $14,805 - $34,095	7,118 Added 6.36%	119,100 $359,000
Q4 2022 Feb 14, 2023	BUY	$1.86 - $3.54 $93,000 - $177,000	50,000 Added 80.67%	111,982 $229,000
Q3 2022 Nov 14, 2022	SELL	$3.82 - $5.61 $191,000 - $280,500	-50,000 Reduced 44.65%	61,982 $214,000
Q2 2022 Aug 15, 2022	SELL	$1.85 - $4.21 $5,450 - $12,402	-2,946 Reduced 2.56%	111,982 $471,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $9.04 $283,324 - $388,069	42,928 Added 59.62%	114,928 $886,000
Q2 2021 Aug 16, 2021	BUY	$6.39 - $11.51 $460,080 - $828,720	72,000 New	72,000 $619,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.